Genistein Affects Adipose Tissue Deposition in a Dose-Dependent and Gender-Specific Manner
- 1 December 2006
- journal article
- Published by The Endocrine Society in Endocrinology
- Vol. 147 (12) , 5740-5751
- https://doi.org/10.1210/en.2006-0365
Abstract
The soy isoflavone genistein targets adipose tissue and elicits physiological effects that may vary based on dietary intake. We hypothesized that the adipose effects of genistein are dose and gender dependent. Four-week-old C57BL/6 male and female mice received daily oral doses of genistein (50–200,000 μg/kg·d) or 17β-estradiol (E2) (5 μg/kg·d) for 15 d or a diet containing 800 ppm genistein. Genistein increased epididymal and renal fat pad and adipocyte size at doses up to 50,000 μg/kg·d or at 800 ppm in the diet in males but not in females. The alteration in adipocity correlated with changes in peripheral insulin resistance. These treatments increased genistein serum concentrations from 35 ± 6 to 103 ± 26 nm 12 h after treatment and lowered plasma triglycerides and cholesterol levels. The 200,000 μg/kg·d genistein dose decreased adipose tissue weight similarly to E2. This genistein dose down-regulated estrogen receptor (β more than α) and progesterone receptor expression and induced estrogen-dependent adipose differentiation factors; it did not change expression of the minimal consensus estrogen-responsive element in ERE-tK-LUC mice, which was positively modulated in other tissues (e.g. the lung). E2 down-regulated almost all examined adipogenic factors. Gene microarray analysis identified factors in fat metabolism and obesity-related phenotypes differentially regulated by low and high doses of genistein, uncovering its adipogenic and antiadipogenic actions. The lower dose induced the phospholipase A2 group 7 and the phospholipid transfer protein genes; the 200,000 μg/kg·d dose inhibited them. The antiadipogenic action of genistein and down-regulation of adipogenic genes required the expression of ERβ. In conclusion, nutritional doses of genistein are adipogenic in a gender-specific manner, whereas pharmacological doses inhibited adipose deposition.Keywords
This publication has 68 references indexed in Scilit:
- Increased expression of inflammation-related genes in cultured preadipocytes/stromal vascular cells from obese compared with non-obese Pima IndiansDiabetologia, 2005
- Development and Characterization of a Cell Line That Stably Expresses an Estrogen-Responsive Luciferase Reporter for the Detection of Estrogen Receptor Agonist and AntagonistsToxicological Sciences, 2004
- Selective Estrogen Receptor Modulators 4-Hydroxytamoxifen and Raloxifene Impact the Stability and Function of SRC-1 and SRC-3 Coactivator ProteinsMolecular and Cellular Biology, 2004
- PLTP activity decreases with weight lossJournal of Lipid Research, 2003
- Urinary equol excretion in relation to 2-hydroxyestrone and 16α-hydroxyestrone concentrations: an observational study of young to middle-aged womenThe Journal of Steroid Biochemistry and Molecular Biology, 2003
- The role of estrogen and estrogen receptor-α in male adipose tissueMolecular and Cellular Endocrinology, 2001
- Obesity and Disturbed Lipoprotein Profile in Estrogen Receptor-α-Deficient Male MiceBiochemical and Biophysical Research Communications, 2000
- REGULATION OF GENE EXPRESSION BY DIETARY FATAnnual Review of Nutrition, 1999
- Identification of Estrogen Receptor β RNA in Human Breast and Abdominal Subcutaneous Adipose TissueBiochemical and Biophysical Research Communications, 1998
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976